View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
February 9, 2017

Accuray’s Radixact system obtains Japan Shonin approval

Radiation oncology firm Accuray has secured Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for its Radixact treatment delivery system, Accuray Precision treatment planning system and iDMS data management system.

Radiation oncology firm Accuray has secured Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for its Radixact treatment delivery system, Accuray Precision treatment planning system and iDMS data management system.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The combination of the treatment delivery system and software solutions is expected to allow clinicians to provide accurate treatment to a wide range of cancer patients as well as to those undergoing retreatment.

The Radixact system is a fully-integrated, simplified adaptive treatment planning solution, which facilitates routine adjustment of treatment plans according to the changes in tumour size, shape and location.

"The newly approved advanced radiation therapy system is an easy to use and reliable device."

Accuray Japan president and general manager Juki Hozumi said: "With the introduction of the Radixact System, we are demonstrating significant progress in fulfilling on this promise.

"This new, mainstream System enables clinicians to deliver the highly sculpted doses for precise, customised treatments the previous TomoTherapy platform was known for, faster, enabling the treatment of more patients every day."

The newly approved advanced radiation therapy system is an easy to use and reliable device.

The system employs a linear accelerator, low-dose fan beam MVCT imaging and a helical treatment mode to enable clinicians to offer individualised dose distributions for all kinds of tumours.

According to a feedback received by the firm from its customers, Radixact system aids in providing precise radiation therapy to more patients in comparitively less time.

The system is now available in Japan, in addition to certain markets in the European Union and the US.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network